Radiology Solutions
Integrated radiology solution within Tempus precision medicine platform
Company profile
Company profile
Arterys is a medical imaging AI platform that has been acquired by Tempus, now operating as Tempus Radiology. The company provides cloud-based AI solutions that extract actionable insights from medical images to add clinical value and improve diagnostic decision making, efficiency, and productivity. The platform allows healthcare providers to weave leading AI clinical applications directly into their existing PACS or EHR driven workflows, making it a natural extension of their current processes. Arterys focuses on improving physician experience, accuracy of diagnosis and treatment, financial performance, and patient outcomes. The platform is accessible anywhere from any validated device via the cloud, offering faster performance and ease of deployment with no PHI exchange while maintaining complete security. Following the acquisition by Tempus, Arterys' product is being integrated into Tempus' solutions, enabling providers to access a comprehensive patient view that includes radiology scans, and allowing researchers to leverage this new data modality to optimize the drug development process. The company serves healthcare providers and researchers in the precision medicine space.
Company description Arterys Radiology official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
Recorded integration context: EHR, PACS.
Company milestones
Acquired by Tempus and rebranded as Tempus Radiology, with product integration into Tempus' precision medicine solutions
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Integrated radiology solution within Tempus precision medicine platform
Cloud-based AI platform for radiology workflow integration
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Platform designed to enhance radiologist workflow
AI-assisted diagnostic decision making
Enhanced efficiency and productivity
Improved diagnostic accuracy and treatment decisions
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Arterys Radiology's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.